A carregar...
Transient Asymptomatic Sinus Bradycardia and Sinus Pauses with Bevacizumab: Case Report and Literature Review
Systemic side effects of anti-cancer therapy remain a major limiting factor for patients, even with targeted therapy. Bevacizumab is an example of targeted cancer therapy which targets the vascular endothelial growth factor receptor (VEGFR) that has been approved for the treatment of various cancers...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913932/ https://ncbi.nlm.nih.gov/pubmed/31890384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.6177 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|